ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways

Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 1999-07, Vol.277 (1), p.H1
Hauptverfasser: Bauer, Johannes, Dau, Cecile, Cavarape, Alessandro, Schaefer, Franz, Ehmke, Heimo, Parekh, Niranjan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page H1
container_title American journal of physiology. Heart and circulatory physiology
container_volume 277
creator Bauer, Johannes
Dau, Cecile
Cavarape, Alessandro
Schaefer, Franz
Ehmke, Heimo
Parekh, Niranjan
description Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and activate protein kinase C (PKC) to elevate vascular tone. The aim of the present study was to determine the importance of these signaling pathways for angiotensin II (ANG II) and thromboxane A 2 (TxA 2 ) in regulating mesenteric blood flow (MBF) in vivo. In anesthetized rats increasing doses of ANG II or the TxA 2 agonist U-46619 were administered into the superior mesenteric artery to reduce MBF. Intra-arterial infusion of inhibitors served to examine the contribution of different pathways: 8-(diethylamino)octyl 3,4,5-trimethoxybenoate hydrochloride (TMB-8) to inhibit intracellular Ca 2+ release, nifedipine to block transmembrane Ca 2+ influx through the L-type Ca 2+ channel, and staurosporine to inhibit PKC. Each of the inhibitors attenuated ANG II-induced reductions in MBF, and all dose-response curves were shifted to the right to an approximately threefold higher ANG II dose. Combinations of the inhibitors revealed that their effects were additive; together they abolished the vasoconstrictor action of ANG II completely. In contrast, the dose-response curve for U-46619 was not affected by any of the inhibitors infused either separately or together. The results demonstrate that a rise in intracellular Ca 2+ and activation of PKC are major mediators of the vasoconstrictor effect of ANG II in mesenteric circulation, but they play a subordinate role, if any, for the effects of TxA 2 . Because TxA 2 plays a major role only under pathological conditions, the uncontrolled vasoconstriction appears to be associated with the recruitment of novel signal transduction pathways. protein kinase C; L-type calcium channels; U-46619; mesenteric blood flow; sensitization
doi_str_mv 10.1152/ajpheart.1999.277.1.h1
format Article
fullrecord <record><control><sourceid>highwire</sourceid><recordid>TN_cdi_highwire_physiology_ajpheart_277_1_H1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ajpheart_277_1_H1</sourcerecordid><originalsourceid>FETCH-LOGICAL-h154t-31af8add8981f6e7f09499bc7a073f6476fc0ad7c7c8f133a9556ffae13de6523</originalsourceid><addsrcrecordid>eNp1kM1OwzAQhC0EoqXwCsgPQII3juP4WFX0R6rgUs7RNrYTVyGJapc2b08k6JHTaGfm28MQ8gwsBhDJKx762uAxxKCUihMpY4hruCHTMUwiEFzdkinjGY8y4GJCHrw_MMaEzPg9mQBLmQKZTkkzf1_RzSai2Gq6u8yTyLX6VBpNv4w3bTBHV9Jv9F3ZtT6MR3BdS11Ljxg8dX6saYdh7O8H6k2Po29oaZqGele12Li2oj2G-oyDfyR3Fhtvnv50Rj6Xb7vFOtp-rDaL-TaqQaQh4oA2R61zlYPNjLRMpUrtS4lMcpulMrMlQy1LWeYWOEclRGYtGuDaZCLhM5L__q1dVZ_d0RR9PXjXNV01FMtT0-zMJRTXCcfxCijWUPTajujL_-iVKK4I_wH2dnlU</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways</title><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bauer, Johannes ; Dau, Cecile ; Cavarape, Alessandro ; Schaefer, Franz ; Ehmke, Heimo ; Parekh, Niranjan</creator><creatorcontrib>Bauer, Johannes ; Dau, Cecile ; Cavarape, Alessandro ; Schaefer, Franz ; Ehmke, Heimo ; Parekh, Niranjan</creatorcontrib><description>Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and activate protein kinase C (PKC) to elevate vascular tone. The aim of the present study was to determine the importance of these signaling pathways for angiotensin II (ANG II) and thromboxane A 2 (TxA 2 ) in regulating mesenteric blood flow (MBF) in vivo. In anesthetized rats increasing doses of ANG II or the TxA 2 agonist U-46619 were administered into the superior mesenteric artery to reduce MBF. Intra-arterial infusion of inhibitors served to examine the contribution of different pathways: 8-(diethylamino)octyl 3,4,5-trimethoxybenoate hydrochloride (TMB-8) to inhibit intracellular Ca 2+ release, nifedipine to block transmembrane Ca 2+ influx through the L-type Ca 2+ channel, and staurosporine to inhibit PKC. Each of the inhibitors attenuated ANG II-induced reductions in MBF, and all dose-response curves were shifted to the right to an approximately threefold higher ANG II dose. Combinations of the inhibitors revealed that their effects were additive; together they abolished the vasoconstrictor action of ANG II completely. In contrast, the dose-response curve for U-46619 was not affected by any of the inhibitors infused either separately or together. The results demonstrate that a rise in intracellular Ca 2+ and activation of PKC are major mediators of the vasoconstrictor effect of ANG II in mesenteric circulation, but they play a subordinate role, if any, for the effects of TxA 2 . Because TxA 2 plays a major role only under pathological conditions, the uncontrolled vasoconstriction appears to be associated with the recruitment of novel signal transduction pathways. protein kinase C; L-type calcium channels; U-46619; mesenteric blood flow; sensitization</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.1999.277.1.h1</identifier><identifier>PMID: 10409174</identifier><language>eng</language><ispartof>American journal of physiology. Heart and circulatory physiology, 1999-07, Vol.277 (1), p.H1</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bauer, Johannes</creatorcontrib><creatorcontrib>Dau, Cecile</creatorcontrib><creatorcontrib>Cavarape, Alessandro</creatorcontrib><creatorcontrib>Schaefer, Franz</creatorcontrib><creatorcontrib>Ehmke, Heimo</creatorcontrib><creatorcontrib>Parekh, Niranjan</creatorcontrib><title>ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways</title><title>American journal of physiology. Heart and circulatory physiology</title><description>Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and activate protein kinase C (PKC) to elevate vascular tone. The aim of the present study was to determine the importance of these signaling pathways for angiotensin II (ANG II) and thromboxane A 2 (TxA 2 ) in regulating mesenteric blood flow (MBF) in vivo. In anesthetized rats increasing doses of ANG II or the TxA 2 agonist U-46619 were administered into the superior mesenteric artery to reduce MBF. Intra-arterial infusion of inhibitors served to examine the contribution of different pathways: 8-(diethylamino)octyl 3,4,5-trimethoxybenoate hydrochloride (TMB-8) to inhibit intracellular Ca 2+ release, nifedipine to block transmembrane Ca 2+ influx through the L-type Ca 2+ channel, and staurosporine to inhibit PKC. Each of the inhibitors attenuated ANG II-induced reductions in MBF, and all dose-response curves were shifted to the right to an approximately threefold higher ANG II dose. Combinations of the inhibitors revealed that their effects were additive; together they abolished the vasoconstrictor action of ANG II completely. In contrast, the dose-response curve for U-46619 was not affected by any of the inhibitors infused either separately or together. The results demonstrate that a rise in intracellular Ca 2+ and activation of PKC are major mediators of the vasoconstrictor effect of ANG II in mesenteric circulation, but they play a subordinate role, if any, for the effects of TxA 2 . Because TxA 2 plays a major role only under pathological conditions, the uncontrolled vasoconstriction appears to be associated with the recruitment of novel signal transduction pathways. protein kinase C; L-type calcium channels; U-46619; mesenteric blood flow; sensitization</description><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNp1kM1OwzAQhC0EoqXwCsgPQII3juP4WFX0R6rgUs7RNrYTVyGJapc2b08k6JHTaGfm28MQ8gwsBhDJKx762uAxxKCUihMpY4hruCHTMUwiEFzdkinjGY8y4GJCHrw_MMaEzPg9mQBLmQKZTkkzf1_RzSai2Gq6u8yTyLX6VBpNv4w3bTBHV9Jv9F3ZtT6MR3BdS11Ljxg8dX6saYdh7O8H6k2Po29oaZqGele12Li2oj2G-oyDfyR3Fhtvnv50Rj6Xb7vFOtp-rDaL-TaqQaQh4oA2R61zlYPNjLRMpUrtS4lMcpulMrMlQy1LWeYWOEclRGYtGuDaZCLhM5L__q1dVZ_d0RR9PXjXNV01FMtT0-zMJRTXCcfxCijWUPTajujL_-iVKK4I_wH2dnlU</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Bauer, Johannes</creator><creator>Dau, Cecile</creator><creator>Cavarape, Alessandro</creator><creator>Schaefer, Franz</creator><creator>Ehmke, Heimo</creator><creator>Parekh, Niranjan</creator><scope/></search><sort><creationdate>19990701</creationdate><title>ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways</title><author>Bauer, Johannes ; Dau, Cecile ; Cavarape, Alessandro ; Schaefer, Franz ; Ehmke, Heimo ; Parekh, Niranjan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h154t-31af8add8981f6e7f09499bc7a073f6476fc0ad7c7c8f133a9556ffae13de6523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bauer, Johannes</creatorcontrib><creatorcontrib>Dau, Cecile</creatorcontrib><creatorcontrib>Cavarape, Alessandro</creatorcontrib><creatorcontrib>Schaefer, Franz</creatorcontrib><creatorcontrib>Ehmke, Heimo</creatorcontrib><creatorcontrib>Parekh, Niranjan</creatorcontrib><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bauer, Johannes</au><au>Dau, Cecile</au><au>Cavarape, Alessandro</au><au>Schaefer, Franz</au><au>Ehmke, Heimo</au><au>Parekh, Niranjan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><date>1999-07-01</date><risdate>1999</risdate><volume>277</volume><issue>1</issue><spage>H1</spage><pages>H1-</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>Physiologisches Institut and Universitäts-Kinderklinik, Ruprecht-Karls-Universität Heidelberg, D-69120 Heidelberg, Germany; and Department of Internal Medicine, University of Udine, I-33100 Udine, Italy Studies in vitro have demonstrated that vasoconstrictor agents increase intracellular Ca 2+ and activate protein kinase C (PKC) to elevate vascular tone. The aim of the present study was to determine the importance of these signaling pathways for angiotensin II (ANG II) and thromboxane A 2 (TxA 2 ) in regulating mesenteric blood flow (MBF) in vivo. In anesthetized rats increasing doses of ANG II or the TxA 2 agonist U-46619 were administered into the superior mesenteric artery to reduce MBF. Intra-arterial infusion of inhibitors served to examine the contribution of different pathways: 8-(diethylamino)octyl 3,4,5-trimethoxybenoate hydrochloride (TMB-8) to inhibit intracellular Ca 2+ release, nifedipine to block transmembrane Ca 2+ influx through the L-type Ca 2+ channel, and staurosporine to inhibit PKC. Each of the inhibitors attenuated ANG II-induced reductions in MBF, and all dose-response curves were shifted to the right to an approximately threefold higher ANG II dose. Combinations of the inhibitors revealed that their effects were additive; together they abolished the vasoconstrictor action of ANG II completely. In contrast, the dose-response curve for U-46619 was not affected by any of the inhibitors infused either separately or together. The results demonstrate that a rise in intracellular Ca 2+ and activation of PKC are major mediators of the vasoconstrictor effect of ANG II in mesenteric circulation, but they play a subordinate role, if any, for the effects of TxA 2 . Because TxA 2 plays a major role only under pathological conditions, the uncontrolled vasoconstriction appears to be associated with the recruitment of novel signal transduction pathways. protein kinase C; L-type calcium channels; U-46619; mesenteric blood flow; sensitization</abstract><pmid>10409174</pmid><doi>10.1152/ajpheart.1999.277.1.h1</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 1999-07, Vol.277 (1), p.H1
issn 0363-6135
1522-1539
language eng
recordid cdi_highwire_physiology_ajpheart_277_1_H1
source American Physiological Society; EZB-FREE-00999 freely available EZB journals
title ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A00%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-highwire&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ANG%20II-%20and%20TxA2-induced%20mesenteric%20vasoconstriction%20in%20rats%20is%20mediated%20by%20separate%20cell%20signaling%20pathways&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Bauer,%20Johannes&rft.date=1999-07-01&rft.volume=277&rft.issue=1&rft.spage=H1&rft.pages=H1-&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.1999.277.1.h1&rft_dat=%3Chighwire%3Eajpheart_277_1_H1%3C/highwire%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10409174&rfr_iscdi=true